Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company founded in 1984 and headquartered in Hyderabad, India. It was founded by Anji Reddy and currently has over 16,000 employees. The company started by producing active pharmaceutical ingredients and launched its first branded drug, Norilet, in 1986. It has since expanded internationally and focuses on both generics and research and development of new drugs. Dr. Reddy's engages in partnerships for research and development and works to provide affordable medicines globally through strategic suppliers. It also focuses on corporate social responsibility programs in education and livelihood advancement.

1. 1 5/8/2016Dr.REDDY’S LABORATORIES

2. Type : Public
Industry : Pharmaceuticals
Founded : 1984
Headquarters : Hyderabad
Key people : Anji Reddy (Founder)
G.V.Prasad (C E O)
Employees : 16,300
DR. REDDY’S LABORATORY
2 5/8/2016Dr.REDDYS LABORATORIES

3. 3
FOUNDER : ANJI REDDY
5/8/2016Dr.REDDYS LABORATORIES

4. 4
ANJI REDDY (FOUNDER)
Indian entrepreneur in the pharmaceuticals industry.
He is the founder and chairman of Reddy Labs, which was
established in year 1984.
The Government of India honored him with Patmabhushan for
his contribution in pharmaceuticals sector.
5/8/2016Dr.REDDYS LABORATORIES

5. 5
CEO : G V
PRASAD
5/8/2016Dr.REDDYS LABORATORIES

6. 6
G V PRASAD ( CEO)
CEO of Dr Reddy’s Laboratories.
His first exposure to the world of pharmaceuticals was in 1985 with
Benzex labs, a pharmaceuticals enterprise which he co founded.
5/8/2016Dr.REDDYS LABORATORIES

7. 7
 Benzex was later acquired by Dr. Reddy’s. In 1990s he
returned to pharmaceuticals sector as the CEO and
Chairman of Cheminor Drugs Ltd.
 In 2001 Cheminor drugs merged with Dr. Reddy’s
Laboratories and C V Prasad took over as the Vice-
Chairman and CEO of the merged entity.
5/8/2016Dr.REDDYS LABORATORIES

8. 8
COMPANY HISTORY
5/8/2016Dr.REDDYS LABORATORIES

9. 9
History
Dr. Reddy's originally launched in 1984 producing active
pharmaceutical ingredients.
In 1986, Reddy's started operations on branded formulations.
Within a year Reddy's had launched Norilet, the company's first
recognized brand in India.
 Soon, Dr. Reddy's obtained another success with Omez, its branded
omeprazole – ulcer and reflux oesophagitis medication – launched at
half the price of other brands on the Indian market at that time.
5/8/2016Dr.REDDYS LABORATORIES

10. 10
Within a year, Reddy's became the first Indian company to
export the active ingredients for pharmaceuticals to Europe.
 In 1987, Reddy's started to transform itself from a supplier of
pharmaceutical ingredients to other manufacturers into a
manufacturer of pharmaceutical products.
5/8/2016Dr.REDDYS LABORATORIES

11. EXPANSION AND
ACQUISITION

12. INTERNATIONA
L EXPANSION
5/8/2016Dr.REDDYS LABORATORIES12
 first international move - Russia in 1992.
 formed a joint venture - Biomed.
 pulled out in 1995 - material loss due to the
activities of Moscow's branch.
 In 1993 - joint venture in the Middle East and
created two formulation units there and in Russia.
 exported bulk drugs to these formulation units,
which then converted them into finished
products..

13. NEW DRUG DISCOVERY
 Dr. Reddy's Research Foundation -1992.
 In 2000- American laboratory in Atlanta
 The laboratory is called Reddy US Therapeutics
Inc (RUSTI) and its main aim is the discovery of
next-generation drugs using genomics and
proteomics.
 anti-cancer, anti-diabetes, cardiovascular and
anti-infection drugs.[

15. GOING GLOBAL
 The year 1997 marked a new era
 transition into generics by filing an Abbreviated
New Drug Application (ANDA) in the USA.
 In 1999, the company made a new acquisition,
buying up American Remedies Limited, based in
Chennai
 the third largest pharmaceutical company in India,
after Ranbaxy and Glaxo (I) Ltd.,
 pharmaceutical products, which included bulk
drugs, intermediates, finished dosages, chemical
synthesis, diagnostics and biotechnology

16. Dr. Reddy's global ambitions
Reddy told Business Week: "We want to be a
truly innovative company discovering and
marketing drugs the world over."

17. 5/8/2016Dr.REDDYS LABORATORIES17
 In June 2011, certain lots of Dr. Reddy's generic
simvastatin tablets were recalled due to tablets
having a "musty" or "moldy" smell.[12]
 On June 24, 2014, the New York Times published
an article "Warning Unheeded, Heart Drugs Are
Recalled”

19. Introduction
 As the world is evolving there is a significant increase in
health concerns and demand for quality health care, which is
affordable.
 We develop products keeping in mind the patient’s need for
cure and comfort.

20.  pharmaceutical products and services cover all major
dosage forms, keeping in mind evolving medical needs
worldwide.
 Our research capabilities, technologies and manufacturing
expertise come together to create high quality and
affordable medicines and services

21. CPSIA
 In accordance with the Consumer Product Safety Act
of 1970, as amended by the Consumer Product Safety
Improvement Act of 2008, in the links below,
searchable by Product name, are Certificates of
Compliance for those products covered under the Act.

22. Top products
Brand Name Molecule Therapy Dosage Form
Acetec Acitretin Dermatology Capsule
Cisplatin Cisplatin Oncology Injection
Clohex Chlorohexidin
e Solution
Dental Mouth Wash
Empov Aprepitant Gastro
Intestinal
Tablet
Finrid Fentanyl BP Pain
Management
Transdermal
Patch

23. Suppliers
 To provide affordable medicines to patients, maintain a
constant supply, remain cost-competitive and ensure
highest levels of quality.
 Business partnerships based on high ethical standards,
mutual business interest, trust and respect.
 Building a social environment by promoting and
increasing inclusion of diverse business partners in the
supply chain.

24. Competitors

25. Competitors
 Sun Pharma
 Lupin
 Cipla
 Ranbaxy Labs
 Cadila Health
5/8/201625 Dr.REDDYS LABORATORIES

26. Comparison among competitors

27. Research and Development Partners

28. Research and Development Partners
 Actively seek out partnerships and collaboration
within the industry that can help in successfully
making high quality and affordable medicines.
 The R&D efforts have been leveraging external
partnerships for one or more parts of the value chain –
development, manufacturing or both.
 Working with nearly 50 partners spread across the
world, with the 3 major clusters being USA, Western
Europe and India.

29. DR REDDY’S FOUNDATION
CORPORATE SOCIAL
RESPONSIBILITY

31. WHAT THEY DO??
 Urban Livelihoods
 Rural Livelihoods
 Education

32. URBAN LIVELIHOODS
• Livelihood Advancement Business
School for Youth (LABS –Y)
• Livelihood Advancement Business
School for People with Disability
(LABS-PwD)

33. RURAL LIVELIHOODS
 Livelihood Advancement Business School
(LABS-F) provides small and marginal
farmers with Knowledge and Methods to
improve agricultural Productivity and Net
income.

34. EDUCATION-KARV CAMPUS
 Kallam Anji Reddy Vidyalaya
-It is an activity Based Teaching
Methodology
 Kallam Anji Reddy Vocational Junior
College -Two Year Vocational Courses
after SSC/Xth

35. PARTNERS